Overexpression of wild-type AXIN1 could suppress the proliferation of HCC cells and accelerate their programmed cell death, which implies that AXIN1 is a therapeutic target in HCC [22]. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.